These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
520 related articles for article (PubMed ID: 29040518)
1. Challenges in comparing the non-vitamin K antagonist oral anticoagulants for atrial fibrillation-related stroke prevention. Camm AJ; Fox KAA; Peterson E Europace; 2018 Jan; 20(1):1-11. PubMed ID: 29040518 [TBL] [Abstract][Full Text] [Related]
2. Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations. Stacy ZA; Richter SK Ther Adv Cardiovasc Dis; 2018 Sep; 12(9):247-262. PubMed ID: 30081727 [TBL] [Abstract][Full Text] [Related]
3. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis. Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644 [TBL] [Abstract][Full Text] [Related]
4. Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials. Cope S; Clemens A; Hammès F; Noack H; Jansen JP Value Health; 2015 Mar; 18(2):234-49. PubMed ID: 25773559 [TBL] [Abstract][Full Text] [Related]
5. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Dillinger JG; Aleil B; Cheggour S; Benhamou Y; Béjot Y; Marechaux S; Delluc A; Bertoletti L; Lellouche N Arch Cardiovasc Dis; 2018 Feb; 111(2):85-94. PubMed ID: 28988597 [TBL] [Abstract][Full Text] [Related]
6. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups. Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548 [TBL] [Abstract][Full Text] [Related]
7. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081 [TBL] [Abstract][Full Text] [Related]
8. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis. Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103 [TBL] [Abstract][Full Text] [Related]
9. Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choice. Li YG; Pastori D; Lip GYH Ann Med; 2018 Jun; 50(4):288-302. PubMed ID: 29608110 [TBL] [Abstract][Full Text] [Related]
10. Non-vitamin K oral anticoagulants in nonvalvular atrial fibrillation: a network meta-analysis. Antza C; Doundoulakis I; Akrivos E; Economou F; Vazakidis P; Haidich AB; Kotsis V Scand Cardiovasc J; 2019 Apr; 53(2):48-54. PubMed ID: 30896311 [TBL] [Abstract][Full Text] [Related]
11. Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation. Moseley A; Doukky R; Williams KA; Jaffer AK; Volgman AS J Womens Health (Larchmt); 2017 Mar; 26(3):214-221. PubMed ID: 27870603 [TBL] [Abstract][Full Text] [Related]
12. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort. Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY; Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063 [TBL] [Abstract][Full Text] [Related]
13. Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation. Deitelzweig S Cardiovasc Ther; 2014 Apr; 32(2):74-81. PubMed ID: 24119252 [TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
15. Relative efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation by network meta-analysis. Fu W; Guo H; Guo J; Lin K; Wang H; Zhang Y; Wang Y; Shan Z J Cardiovasc Med (Hagerstown); 2014 Dec; 15(12):873-9. PubMed ID: 25304034 [TBL] [Abstract][Full Text] [Related]
16. Non-vitamin K antagonist oral anticoagulants: new choices for patient management in atrial fibrillation. Saliba W Am J Cardiovasc Drugs; 2015 Oct; 15(5):323-35. PubMed ID: 26055615 [TBL] [Abstract][Full Text] [Related]
17. Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. Nielsen PB; Lane DA; Rasmussen LH; Lip GY; Larsen TB Clin Res Cardiol; 2015 May; 104(5):418-29. PubMed ID: 25416564 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Non-Vitamin K Anticoagulants for Atrial Fibrillation in Relation to Different Renal Function Levels: A Network Meta-Analysis. Jin H; Zhu K; Wang L; Li Y; Meng J; Zhi H Cardiovasc Ther; 2020; 2020():2683740. PubMed ID: 32405322 [TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves. Malik AH; Yandrapalli S; Aronow WS; Panza JA; Cooper HA Heart; 2019 Sep; 105(18):1432-1436. PubMed ID: 31203254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]